UMIN ID: UMIN000001175
Registered date:01/07/2008
analysis of immunocytes in patients with brain tumor treated with temozolomide
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | brain tumor |
Date of first enrollment | 2007/03/01 |
Target sample size | 20 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | We collect blood from the patients before taking temozolomide, after 3 and 6 weeks after taking temozolomide, and every 4-8 weeks after that. We extract the lymphocyte of the blood and analyze the immunocytes including WT1 peptide-specific CD8-positive killer T-cell. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | no |
Related Information
Primary Sponsor | Department of Neurosurgery, Osaka University Graduate School of Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Education, Culture, Sports, Science and Technology |
Secondary ID(s) |
Contact
public contact | |
Name | Chiba Yasuyoshi |
Address | Japan |
Telephone | 06-6879-3652 |
ychiba@nsurg.med.osaka-u.ac.jp | |
Affiliation | Osaka University Graduate School of Medicine Department of Neurosurgery |
scientific contact | |
Name | Toshiki Yoshmine |
Address | 2-2 Yamada-oka, Suita-city, Osaka, Japan Japan |
Telephone | 06-6879-3652 |
Affiliation | Osaka University Graduate School of Medicine Department of Neurosurgery |